Dr. Keith Kerman is an operating partner and senior advisor with The Riverside Company, a global private equity firm focused on growth businesses. Dr. Kerman has 20 years of experience in health care related to private equity, venture capital, and operating roles and has been an executive, investor, and board member at numerous health care businesses and organizations. Prior to joining Riverside, Dr. Kerman was a managing director and led the health care practice at Primus Capital Funds, a growth equity and middle market buyout firm, and was previously a general partner with Morgenthaler Ventures. Dr. Kerman also was an operating executive at U.S. Healthcare, where he was president of the company’s subsidiary, providing managed care services to self-funded health plans. Prior to joining U.S. Healthcare, he was a Robert Wood Johnson Foundation clinical scholar at the University of Pennsylvania, was a member of the clinical faculty at the Hospital of the University of Pennsylvania, and was a senior fellow at the Leonard Davis Institute for Health Economics at The Wharton School.
He has a bachelor’s degree and a medical degree from Brown University and a master of business administration from The Wharton School of the University of Pennsylvania. Dr. Kerman currently serves on the board of directors of AxioMed Spine Corporation, Cleveland Heart Labs, IDOC, and Physicians Pharmacy Alliance. He also serves on the worldwide board of directors of the Healthcare Information Management Systems Society (HIMSS).